These Are The Top Priorities & Challenges For New CDER Director Patrizia Cavazzoni, M.D.

Partner Lynn Mehler and Counsel Lowell Zeta pen a guest column for Life Sciences Connect where they discuss the recent appointment of a new Center for Drug Evaluation and Research director and what this will mean for evolving FDA’s regulatory programs and drug review policies.

Click here to read the full article.

Back To Listing